We are strong in the oncology field – our current assets address the most common and deadly types of cancer: breast, pancreatic, lung, colorectal, gastric, and glioblastoma.
Yet our portfolio is now expanding into advanced health tech, nano-robotics, AI, virtual reality, telemedicine, data distribution and governance, and other digital health solutions.
In 2023, we’ll be hosting a Demo Day in the UAE, an unparalleled networking opportunity to connect innovators with the financial resources they need to take their projects forward.
We foresee scaling to 15-20 portfolio companies in 2023-2024.
Get the best industry insights by signing up for our monthly newsletter:
Copyright © 2024 Infusion 51a, LP
Follow us:
A revolutionary brand dedicated to enhancing overall health and well-being through a unique combination of cold therapy, oxygen therapy, and fitness solutions like mobility, breathing as well as Nutrition Support etc., It’s a fitness health club not only for people who are fit body enthusiastic but also who wants to heal their mind body and soul
Precise Generics is a precision-based enterprise optimizing generic drug development and targeting companion diagnostics to enhance to provide patients and physicians with more efficient alternatives.
Vivacitas is a biopharmaceutical company using artificial intelligence technology and advanced imaging strategies to develop innovative cancer therapies.